Harris Todd
SEC CIK 1711463 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TYRA | Tyra Biosciences, Inc. | Pres, CEO, Dir | 1.44M | — | $8.12M | 28 | 2021-09-17 | 2026-09-15 |
Most active insiders at TYRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MORE ROBERT J | Dir | — | $5.25M |
| 2 | Bensen Daniel | Chief Discovery Off | — | $4.81M |
| 3 | KAPLAN GILLA | Dir | — | $528.5K |
| 4 | Verjee Rehan | Dir | $20.0K | — |
| 5 | Rueb Yuliya | VP, Fin (PAO) | — | — |
| 6 | Warner Douglas J | Chief Medical Off | — | — |
| 7 | Ashar Bhavesh | COO | — | — |
| 8 | Harris Todd | Pres, CEO, Dir | — | — |
| 9 | Fuhrman Alan | CFO | — | — |
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 19:29 | 2026-09-15 | TYRA | Tyra Biosciences, Inc. | Harris Todd | Pres, CEO, Dir | A - Grant | $9.13 | +864 | 1.44M | +0.1% | +$7,887 | |
| D | 2026-05-07 16:30 | 2026-05-05 | TYRA | Tyra Biosciences, Inc. | Harris Todd | Pres, CEO, Dir | A - Grant | $0.00 | +79.0K | 1.44M | +6% | $0 |
| 2026-03-17 | 2026-03-13 | TYRA | Tyra Biosciences, Inc. | Harris Todd | Pres, CEO, Dir | A - Grant | $9.13 | +1,463 | 1.36M | +0.1% | +$13.4K | |
| 2025-03-18 | 2025-03-14 | TYRA | Tyra Biosciences, Inc. | Harris Todd | Pres, CEO, Dir | A - Grant | $9.78 | +1,241 | 1.36M | +0.1% | +$12.1K | |
| MT | 2024-10-22 | 2024-10-18+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | Pres, CEO, Dir | S - Sale | $27.28 | -62.7K | 1.37M | -4% | -$1.71M |
| MT | 2024-10-17 | 2024-10-15+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | Pres, CEO, Dir | S - Sale | $25.77 | -58.7K | 1.44M | -4% | -$1.51M |
| T | 2024-10-02 | 2024-09-30 | TYRA | Tyra Biosciences, Inc. | Harris Todd | Pres, CEO, Dir | S - Sale | $24.00 | -500 | 1.48M | -0.0% | -$12.0K |
| MT | 2024-09-25 | 2024-09-23+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | Pres, CEO, Dir | S - Sale | $24.11 | -11.7K | 1.48M | -0.8% | -$283.3K |
| MT | 2024-09-20 | 2024-09-18+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | Pres, CEO, Dir | S - Sale | $24.19 | -16.3K | 1.50M | -1% | -$394.4K |
| 2024-09-17 | 2024-09-13 | TYRA | Tyra Biosciences, Inc. | Harris Todd | Pres, CEO, Dir | A - Grant | $6.58 | +1,350 | 1.51M | +0.1% | +$8,883 | |
| 2024-03-19 | 2024-03-15 | TYRA | Tyra Biosciences, Inc. | Harris Todd | Pres, CEO, Dir | A - Grant | $6.58 | +1,880 | 1.50M | +0.1% | +$12.4K | |
| MT | 2024-02-06 | 2024-02-02+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | Pres, CEO, Dir | S - Sale | $16.56 | -100.0K | 1.52M | -6% | -$1.66M |
| 2023-09-19 | 2023-09-15 | TYRA | Tyra Biosciences, Inc. | Harris Todd | Pres, CEO, Dir | A - Grant | $6.58 | +1,421 | 1.60M | +0.1% | +$9,350 | |
| M | 2023-06-26 | 2023-06-22+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | S - Sale | $17.01 | -24.2K | 1.60M | -1% | -$411.5K |
| M | 2023-06-21 | 2023-06-16+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | S - Sale | $17.12 | -75.8K | 1.63M | -4% | -$1.30M |
| DM | 2023-06-15 | 2023-06-13+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | S - Sale+OE | $16.08 | -20.7K | 1.70M | -1% | -$332.9K |
| DM | 2023-06-15 | 2023-06-13+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +20.7K | 1.71M | +1% | +$46.6K |
| D | 2023-04-05 | 2023-04-03 | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | S - Sale+OE | $16.13 | -2,000 | 1.70M | -0.1% | -$32.3K |
| D | 2023-04-05 | 2023-04-03 | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +2,000 | 1.70M | +0.1% | +$4,500 |
| DM | 2023-03-31 | 2023-03-29+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +4,327 | 1.70M | +0.3% | +$9,736 |
| DM | 2023-03-31 | 2023-03-29+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | S - Sale+OE | $16.08 | -4,327 | 1.70M | -0.3% | -$69.6K |
| DM | 2023-03-28 | 2023-03-24+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | S - Sale+OE | $16.00 | -5,912 | 1.70M | -0.3% | -$94.6K |
| DM | 2023-03-28 | 2023-03-24+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +5,912 | 1.70M | +0.3% | +$13.3K |
| DM | 2023-03-23 | 2023-03-21+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +19.2K | 1.70M | +1% | +$43.3K |
| DM | 2023-03-23 | 2023-03-21+ | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | S - Sale+OE | $16.00 | -19.2K | 1.70M | -1% | -$307.8K |
| 2023-03-17 | 2023-03-15 | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | A - Grant | $6.58 | +1,808 | 1.70M | +0.1% | +$11.9K | |
| D | 2022-09-08 | 2022-03-15 | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | A - Grant | $8.53 | +3,125 | 1.70M | +0.2% | +$26.7K |
| D | 2021-09-17 | 2021-09-17 | TYRA | Tyra Biosciences, Inc. | Harris Todd | CEO, Dir | C - Cnv Deriv | — | +34.0K | 1.70M | +2% | — |
Purchase Sale Sale after option exercise All abbreviations